Phentermine and Combination Agents Phentermine remains a useful tool in the weight management pharmacopeia, particularly for patients who cannot access or tolerate GLP-1 agonists
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program
"Epitan changes name to Clinuvel, announces new clinical program"
Mazdutide Mazdutide is the worlds first approved GCG/GLP-1 dual receptor agonist , jointly developed by Innovent Biologics and Eli Lilly and Company
A trial of saxagliptin (SAVOR-TIMI53) studied 16,492 patients with diabetes who were followed for a median of 2.1 years [49]
In a recent study published in the New England Journal of Medicine , a group of researchers evaluated the effectiveness of a combined regimen of cagrilintide and semaglutide in reducing body weight and its safety for adults with obesity but without diabetes